Teriflunomide in MS: Added benefit not proven

Aubagio is an oral treatment approved for MS.

Teriflunomide in MS: Added benefit not proven

Postby MSUK » Wed Jan 08, 2014 2:57 am

Teriflunomide (trade name: Aubagio) has been approved in Germany since August 2013 for adults with relapsing remitting multiple sclerosis. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the appropriate comparator therapy specified by the Federal Joint Committee (G-BA)....... Read More - http://www.ms-uk.org/aubagio
MS-UK - http://www.ms-uk.org/
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to Aubagio (teriflunomide)


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service